Cargando…
Radiation field size and dose determine oncologic outcome in esophageal cancer
BACKGROUND: Locoregional recurrence is a major problem in esophageal cancer patients treated with definitive concomitant chemoradiotherapy. Approximately half of the patients fail locoregionally. We analyzed the impact of enlarged radiation field size and higher radiation dose incorporated to chemor...
Autores principales: | Gemici, Cengiz, Yaprak, Gokhan, Batirel, Hasan Fevzi, Ilhan, Mahmut, Mayadagli, Alpaslan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064926/ https://www.ncbi.nlm.nih.gov/pubmed/27737673 http://dx.doi.org/10.1186/s12957-016-1024-0 |
Ejemplares similares
-
Is there any role of intravenous iron for the treatment of anemia in cancer?
por: Gemici, Cengiz, et al.
Publicado: (2016) -
Covid-19 outbreak in a major radiation oncology department; which lessons should be taken?()
por: Gemici, Cengiz, et al.
Publicado: (2020) -
Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
por: Gemici, Cengiz, et al.
Publicado: (2015) -
CT Derived Hounsfield Unit: An Easy Way to Determine Osteoporosis and Radiation Related Fracture Risk in Irradiated Patients
por: Yaprak, Gokhan, et al.
Publicado: (2020) -
Pretreatment SUV(max) value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy
por: Yaprak, Gokhan, et al.
Publicado: (2019)